Myxoid Neoplasms

Surgical Pathology Clinics

Volumn 4, Issue 3, 2011, Pages 843-864

  Zulfiqar, Muhammad I ^a   Sheikh, Umer N ^a   Montgomery, Elizabeth A ^b  

^a ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Benign lesions; Cutaneous myxoma; Intramuscular myxoma; Malignant neoplasms; Myxoid neoplasms

Indexed keywords

CANCER DIAGNOSIS; CHROMOSOME ANALYSIS; CUTANEOUS MYXOMA; DIFFERENTIAL DIAGNOSIS; EXTRASKELETAL MYXOID CHONDROSARCOMA; FIBROMYXOSARCOMA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAMUSCULAR MYXOMA; LOW GRADE FIBROMYXOID SARCOMA; MYXOID CANCER; MYXOINFLAMMATORY FIBROBLASTIC SARCOMA; MYXOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOFT TISSUE CANCER; SUPERFICIAL ACRAL FIBROMYXOMA;

EID: 80053999833     PISSN: 18759181     EISSN: 18759157     Source Type: Journal    
DOI: 10.1016/j.path.2011.08.012     Document Type: Review

References (32)

1. Al-Daraji W.I., Miettinen M. Superficial acral fibromyxoma: a clinicopathological analysis of 32 tumors including 4 in the heel. J Cutan Pathol 2008, 35(11):1020-1026.
2. Fetsch J.F., Laskin W.B., Miettinen M. Superficial acral fibromyxoma: a clinicopathologic and immunohistochemical analysis of 37 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes. Hum Pathol 2001, 32(7):704-714.
3. Allen P.W., Dymock R.B., MacCormac L.B. Superficial angiomyxomas with and without epithelial components. Report of 30 tumors in 28 patients. Am J Surg Pathol 1988, 12(7):519-530.
4. Fetsch J.F., Laskin W.B., Tavassoli F.A. Superficial angiomyxoma (cutaneous myxoma): a clinicopathologic study of 17 cases arising in the genital region. Int J Gynecol Pathol 1997, 16(4):325-334.
5. Carney J.A. Carney complex: the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas. Semin Dermatol 1995, 14(2):90-98.
6. Kindblom L.G., Stener B., Angervall L. Intramuscular myxoma. Cancer 1974, 34(5):1737-1744.
7. Nielsen G.P., O'Connell J.X., Rosenberg A.E. Intramuscular myxoma: a clinicopathologic study of 51 cases with emphasis on hypercellular and hypervascular variants. Am J Surg Pathol 1998, 22(10):1222-1227.
8. Wirth W.A., Leavitt D., Enzinger F.M. Multiple intramuscular myxomas. Another extraskeletal manifestation of fibrous dysplasia. Cancer 1971, 27(5):1167-1173.
9. Kilpatrick S.E., Doyon J., Choong P.F., et al. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer 1996, 77(8):1450-1458.
10. Smith T.A., Easley K.A., Goldblum J.R. Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma. Am J Surg Pathol 1996, 20(2):171-180.
11. Antonescu C.R., Elahi A., Healey J.H., et al. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements. Clin Cancer Res 2000, 6(7):2788-2793.
12. Tallini G., Akerman M., Dal Cin P., et al. Combined morphologic and karyotypic study of 28 myxoid liposarcomas. Implications for a revised morphologic typing (a report from the CHAMP Group). Am J Surg Pathol 1996, 20(9):1047-1055.
13. Spillane A.J., Fisher C., Thomas J.M. Myxoid liposarcoma-the frequency and the natural history of nonpulmonary soft tissue metastases. Ann Surg Oncol 1999, 6(4):389-394.
14. Weiss S.W., Enzinger F.M. Myxoid variant of malignant fibrous histiocytoma. Cancer 1977, 39(4):1672-1685.
15. Mentzel T., Calonje E., Wadden C., et al. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 1996, 20(4):391-405.
16. Meis-Kindblom J.M., Bergh P., Gunterberg B., et al. Extraskeletal myxoid chondrosarcoma. A reappraisal of its morphologic spectrum and prognostic factors based on 117 cases. Am J Surg Pathol 1999, 23:636-650.
17. Enzinger F.M., Shiraki M. Extraskeletal myxoid chondrosarcoma. An analysis of 34 cases. Hum Pathol 1972, 3(3):421-435.
18. Antonescu C.R., Argani P., Erlandson R.A., et al. Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study. Cancer 1998, 83:1504-1521.
19. Domanski H.A., Carlén B., Mertens F., et al. Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: a case report with fine-needle aspiration biopsy, histopathology, electron microscopy, and cytogenetics. Ultrastruct Pathol 2003, 27(5):363-368.
20. Goh Y.W., Spagnolo D.V., Platten M., et al. Extraskeletal myxoid chondrosarcoma: a light microscopic, immunohistochemical, ultrastructural and immuno-ultrastructural study indicating neuroendocrine differentiation. Histopathology 2001, 39:514-524.
21. Okamoto S., Hisaoka M., Ishida T., et al. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases. Hum Pathol 2001, 32(10):1116-1124.
22. Folpe A.L., Lane K.L., Paull G., et al. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas. Am J Surg Pathol 2000, 24(10):1353-1360.
23. Evans H.L. Low-grade fibromyxoid sarcoma. A report of 12 cases. Am J Surg Pathol 1993, 17(6):595-600.
24. Billings S.D., Giblen G., Fanburg-Smith J.C. Superficial low-grade fibromyxoid sarcoma (Evans tumor): a clinicopathologic analysis of 19 cases with a unique observation in the pediatric population. Am J Surg Pathol 2005, 29(2):204-210.
25. Reid R., de Silva M.V., Paterson L., et al. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes share a common t(7;16)(q34;p11) translocation. Am J Surg Pathol 2003, 27(9):1229-1236.
26. Mertens F., Fletcher C.D., Antonescu C.R., et al. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest 2005, 85(3):408-415.
27. Guillou L., Benhattar J., Gengler C., et al. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. Am J Surg Pathol 2007, 31(9):1387-1402.
28. Doyle L.A., Möller E., Dal Cin P., et al. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol 2011, 35(5):733-741.
29. Bhattacharya B., Dilworth H.P., Iacobuzio-Donahue C., et al. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol 2005, 29(5):653-659.
30. Montgomery E.A., Devaney K.O., Giordano T.J., et al. Inflammatory myxohyaline tumor of distal extremities with virocyte or Reed-Sternberg-like cells: a distinctive lesion with features simulating inflammatory conditions, Hodgkin's disease, and various sarcomas. Mod Pathol 1998, 11(4):384-391.
31. Meis-Kindblom J.M., Kindblom L.G. Acral myxoinflammatory fibroblastic sarcoma: a low-grade tumor of the hands and feet. Am J Surg Pathol 1998, 22(8):911-924.
32. Antonescu C.R., Zhang L., Nielsen G.P., et al. Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor. Genes Chromosomes Cancer 2011, 50(10):757-764.